Benjamin H. Kaffenberger

home / authors / benjamin-h-kaffenberger

Articles

15 Updated Expert Consensus Recommendations for Managing Hyperglycemia and Rash in Patients With PIK3CA-Mutated, Hormone Receptor–Positive (HR+), Human Epidermal Growth Factor Receptor 2–Negative (HER2–) Advanced Breast Cancer Treated With Alpelisib

15 Updated Expert Consensus Recommendations for Managing Hyperglycemia and Rash in Patients With PIK3CA-Mutated, Hormone Receptor–Positive (HR+), Human Epidermal Growth Factor Receptor 2–Negative (HER2–) Advanced Breast Cancer Treated With Alpelisib

Emily J. Gallagher;Heather Moore;Mario E. Lacouture, MD;Susan F. Dent;Azeez Farooki, MD;Marcus D. Goncalves;Claudine Isaacs, MD;Abigail Johnston;Dejan Juric;Zoe Quandt;Laura Spring;Brian Berman;Melanie Decker;Gabriel N. Hortobagyi, MD, FACP;Benjamin H. Kaffenberger;Bernice Y. Kwong;Timothy Pluard;Ruta Rao, MD;Lee Schwartzberg, MD, FACP;Michael S. Broder
April 28th 2023

Latest Updated Articles

Non–clear Cell RCC: First-Line Treatment Options and Guideline Updates
Published: September 13th 2024 | Updated: November 25th 2024
Non–clear Cell RCC: First-Line Treatment Options and Guideline Updates
NSABP B-42 trial results show that the assay was predictive of extended letrozole therapy response, identifying a patient subset with improved outcomes.
Published: August 9th 2024 | Updated: August 14th 2024
Gene Assay May Predict Extended Letrozole Benefits in Breast Cancer Subsets
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Published: June 2nd 2024 | Updated: June 3rd 2024
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Data from the CheckMate-67T trial support the biologics license application for subcutaneous nivolumab in multiple solid tumors.
Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab in Solid Tumor Indications
NSCLC Patient Develops Fever and Rash Following Treatment for Brain Metastases
Published: July 31st 2012 | Updated: December 24th 2024
NSCLC Patient Develops Fever and Rash Following Treatment for Brain Metastases
Patient With Supraglottic Squamous Cell Carcinoma Develops Painful Swelling on Both Great Toes
Published: August 26th 2011 | Updated: December 24th 2024
Patient With Supraglottic Squamous Cell Carcinoma Develops Painful Swelling on Both Great Toes